Logo

Decode to Raise $30M in Stock Offering

Jul 14, 2006

NEW YORK (GenomeWeb News) - Decode Genetics plans to raise $30 million in a common stock offering to new and existing institutional investors, the company said today.

 
Decode said it will sell 6 million shares at $5 apiece. The shares closed at $5.68 yesterday. The company expects net proceeds after expenses to be approximately $27.8 million.
 
Decode said it expects to close the transaction on or about July 18.

Breaking News
The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.